These results indicate that EGCG can reduce the gelatinases activity of NPC cells though suppression of ERK phosphorylation, which results in inhibition of AP-1 and Sp1-mediate MMP expression (Figure 4D). The gene discussed is SP1; the disease is nasopharyngeal carcinoma.